content: <?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:56568f5c-7c43-4133-8373-120669be4f7b,g:b1ddc87f-5c8b-4c32-959c-7e22e0b8627b,d:64cbab109a6341acb3c8fe5a9f6a8625--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>
  
  
  <title>cah-20220225</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV80L2ZyYWc6NDRmNzI2NWE0NWU4NDA2Y2E0ZTlmZTU3MTNhM2U4NTYvdGFibGU6NjMyZTU1MGFlZTM2NDg5MThiNGFiZTc5YzJkNzU1MjUvdGFibGVyYW5nZTo2MzJlNTUwYWVlMzY0ODkxOGI0YWJlNzljMmQ3NTUyNV8xLTEtMS0xLTEzMTE4Nw_3a43c22c-e07d-4267-a5c9-280c69d08c7d">0000721371</ix:nonNumeric><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV80L2ZyYWc6NDRmNzI2NWE0NWU4NDA2Y2E0ZTlmZTU3MTNhM2U4NTYvdGFibGU6NjMyZTU1MGFlZTM2NDg5MThiNGFiZTc5YzJkNzU1MjUvdGFibGVyYW5nZTo2MzJlNTUwYWVlMzY0ODkxOGI0YWJlNzljMmQ3NTUyNV8yLTEtMS0xLTEzMTE4Nw_641751af-3f40-4fe8-a151-b36edf416804">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cah-20220225.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-02</xbrli:startDate><xbrli:endDate>2021-04-02</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i64cbab109a6341acb3c8fe5a9f6a8625_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGV4dHJlZ2lvbjo0MjQzYTJjYTdhM2Q0NTA3ODg4YjZiZGNlMDBhZjk3OV82OTU_a867bcf1-3a27-4cb1-b510-f0deeca83a65">8-K</ix:nonNumeric> </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGV4dHJlZ2lvbjo0MjQzYTJjYTdhM2Q0NTA3ODg4YjZiZGNlMDBhZjk3OV8yMjQ_9ccf0c21-c660-48f5-9e43-e86ecf7578f9">February 25, 2022</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGV4dHJlZ2lvbjo0MjQzYTJjYTdhM2Q0NTA3ODg4YjZiZGNlMDBhZjk3OV82OTY_39d78290-a95e-49c3-a61a-44061fcd88c3">Cardinal Health, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in Charter)</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.751%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGFibGU6OGYzMmMzYjVlNWM4NDgzY2FjMjlhZGIzMmNjNzlmYzQvdGFibGVyYW5nZTo4ZjMyYzNiNWU1Yzg0ODNjYWMyOWFkYjMyY2M3OWZjNF8xLTAtMS0xLTEzMTE4Nw_20de8147-1d4b-499c-bc1e-43f7ba8e5a40">Ohio</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGFibGU6OGYzMmMzYjVlNWM4NDgzY2FjMjlhZGIzMmNjNzlmYzQvdGFibGVyYW5nZTo4ZjMyYzNiNWU1Yzg0ODNjYWMyOWFkYjMyY2M3OWZjNF8xLTItMS0xLTEzMTE4Nw_8eef2835-39e7-4a6d-b81a-71b1f949c2a1">1-11373</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGFibGU6OGYzMmMzYjVlNWM4NDgzY2FjMjlhZGIzMmNjNzlmYzQvdGFibGVyYW5nZTo4ZjMyYzNiNWU1Yzg0ODNjYWMyOWFkYjMyY2M3OWZjNF8xLTQtMS0xLTEzMTE4Nw_7db2e2bd-a24f-4a5a-b16e-947b3f05236a">31-0958666</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or Other Jurisdiction<br/>of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGV4dHJlZ2lvbjo0MjQzYTJjYTdhM2Q0NTA3ODg4YjZiZGNlMDBhZjk3OV82OTc_62286952-9acd-4137-9c14-ed26d6009983">7000 Cardinal Place</ix:nonNumeric>, <ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGV4dHJlZ2lvbjo0MjQzYTJjYTdhM2Q0NTA3ODg4YjZiZGNlMDBhZjk3OV82OTg_f0de49e0-91f7-40a0-89e8-3d43b7ef847a">Dublin</ix:nonNumeric>, <ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGV4dHJlZ2lvbjo0MjQzYTJjYTdhM2Q0NTA3ODg4YjZiZGNlMDBhZjk3OV82OTk_360871b5-c0f7-4763-ac63-41e3aa3b143b">Ohio</ix:nonNumeric> <ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGV4dHJlZ2lvbjo0MjQzYTJjYTdhM2Q0NTA3ODg4YjZiZGNlMDBhZjk3OV83MDA_ccbe1eee-feca-4518-ad1a-ae210a0a4ca4">43017</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGV4dHJlZ2lvbjo0MjQzYTJjYTdhM2Q0NTA3ODg4YjZiZGNlMDBhZjk3OV83MDE_350d57bf-2ae4-4bd1-ad5f-0a93f33331f5">614</ix:nonNumeric>) <ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGV4dHJlZ2lvbjo0MjQzYTJjYTdhM2Q0NTA3ODg4YjZiZGNlMDBhZjk3OV82OTQ_b2a97e42-3f42-4dcb-9546-9763ab973975">757-5000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General Instruction A.2. below):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGFibGU6MzZiMGJjNDYyNGI5NGEzNzg4ZTY2NzhjMzZlNzg3OTIvdGFibGVyYW5nZTozNmIwYmM0NjI0Yjk0YTM3ODhlNjY3OGMzNmU3ODc5Ml8wLTAtMS0xLTEzMTE4Nw_f2392689-4850-4b85-9471-ec28d06cf64a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGFibGU6NjRlZDAyZDYwODQyNGJkY2FlNjJkNzdmZjNlNmNhYWEvdGFibGVyYW5nZTo2NGVkMDJkNjA4NDI0YmRjYWU2MmQ3N2ZmM2U2Y2FhYV8wLTAtMS0xLTEzMTE4Nw_f1075c3f-f1b9-4880-b6da-db951aaaf642">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGFibGU6NzIwYjkxOWRjMzZhNDI5ZGExNzI2ZmRmZTI4ZjNjOGYvdGFibGVyYW5nZTo3MjBiOTE5ZGMzNmE0MjlkYTE3MjZmZGZlMjhmM2M4Zl8wLTAtMS0xLTEzMTE4Nw_b7fa8116-0920-4c0a-8d47-b2ea3af9ef14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGFibGU6NjM4MjdjNTU5NzM5NDdlNDg1NDk2MGQ2YmJjMDMxNDgvdGFibGVyYW5nZTo2MzgyN2M1NTk3Mzk0N2U0ODU0OTYwZDZiYmMwMzE0OF8wLTAtMS0xLTEzMTE4Nw_f14da499-a63a-464b-a081-b9c383ef58d2">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:31.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGFibGU6MTYzY2E3YTdkZjcyNDUyMGFkNzY0NjI5NjM5ZjUwMTAvdGFibGVyYW5nZToxNjNjYTdhN2RmNzI0NTIwYWQ3NjQ2Mjk2MzlmNTAxMF8yLTAtMS0xLTEzMTE4Nw_bdfb47b6-4424-4fcf-9d23-a1a9fa86ab69">Common shares (without par value)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGFibGU6MTYzY2E3YTdkZjcyNDUyMGFkNzY0NjI5NjM5ZjUwMTAvdGFibGVyYW5nZToxNjNjYTdhN2RmNzI0NTIwYWQ3NjQ2Mjk2MzlmNTAxMF8yLTEtMS0xLTEzMTE4Nw_39317b42-fad3-481c-be04-ac7b6b606510">CAH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGFibGU6MTYzY2E3YTdkZjcyNDUyMGFkNzY0NjI5NjM5ZjUwMTAvdGFibGVyYW5nZToxNjNjYTdhN2RmNzI0NTIwYWQ3NjQ2Mjk2MzlmNTAxMF8yLTItMS0xLTEzMTE4Nw_dcc586e3-4588-49e1-b0f2-13e7364e3a55">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:92.301%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). <br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01f786fb09374c398ee33a67da60bcb2_D20210402-20210402" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjY0Y2JhYjEwOWE2MzQxYWNiM2M4ZmU1YTlmNmE4NjI1L3NlYzo2NGNiYWIxMDlhNjM0MWFjYjNjOGZlNWE5ZjZhODYyNV8xL2ZyYWc6NDI0M2EyY2E3YTNkNDUwNzg4OGI2YmRjZTAwYWY5NzkvdGFibGU6OWJlNGQ0MTc1ODNjNDNhMzkyNjM3ZjFlZjJmODhiNmUvdGFibGVyYW5nZTo5YmU0ZDQxNzU4M2M0M2EzOTI2MzdmMWVmMmY4OGI2ZV8xLTEtMS0xLTEzMTE4Nw_fa6a02f1-19eb-4df7-9c4d-4ba556154fc6">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></div><div><span><br/></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i64cbab109a6341acb3c8fe5a9f6a8625_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 1.01. Entry into a Material Definitive Agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of February 25, 2022, Cardinal Health, Inc. (the &#8220;Company&#8221;) and two other national pharmaceutical distributors (collectively, the &#8220;Distributors&#8221;) announced that each had independently determined that there is sufficient state and litigating subdivision participation to enter into the previously disclosed proposed settlement agreement (the &#8220;Settlement Agreement&#8221;) to settle a substantial majority of opioid lawsuits filed by states and local governmental entities. The Settlement Agreement requires that participating states and territories, together with the Distributors, seek court-ordered consent judgments embodying the terms of the Settlement Agreement, which is anticipated to become effective on April 2, 2022.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the terms of the Settlement Agreement, the Company would pay the participating states, territories and local governmental entities (the &#8220;Settling Governmental Entities&#8221;) up to $6.0 billion over 18 years. A minimum of 85% of settlement payments must be used by the Settling Governmental Entities to remediate the opioid epidemic. The majority of the remaining payment amounts will be applied towards plaintiffs&#8217; attorneys&#8217; fees and costs. The Settlement Agreement also includes injunctive relief terms related to the Distributors&#8217; controlled substance anti-diversion programs. A monitor will be selected to oversee compliance with these provisions for a period of five years. The Distributors will also engage a third-party vendor to act as a clearinghouse for data aggregation and reporting, which the Distributors will fund for ten years and which will be available to the participating states to use in their anti-diversion efforts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The states of Florida, New York, Ohio, Rhode Island and Texas and their participating subdivisions, which have separate agreements with the Distributors, will participate in the Settlement Agreement pursuant to the terms of their separate agreements. As of the date of this Form 8-K, 46 of 49 eligible states, as well as the District of Columbia and all eligible U.S. territories, have agreed to join the Settlement Agreement. West Virginia subdivisions and Native American Tribes are not a part of the Settlement Agreement. A list of the states and territories that have agreed to the Settlement Agreement is attached hereto as Exhibit 99.1. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 7.01. Regulation FD Disclosure</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Distributors issued a joint news release on February 25, 2022 to announce the Settlement. A copy of this news release is attached to this Form 8-K as Exhibit 99.2. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 9.01 Financial Statements and Exhibits </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">              </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) Exhibits </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">99.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a2022globalsettlementagree.htm">List of participating states and territories</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">99.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a2022globalsettlementagree.htm">Joint news release issued by the Distributors on February 25, 2022</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i64cbab109a6341acb3c8fe5a9f6a8625_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Signatures</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardinal Health, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 25, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;JESSICA L. MAYER</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jessica L. Mayer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Legal and Compliance Officer</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div></body></html>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "cah-20220225.htm", "description": "8-K", "secsgml_size_bytes": 37797}]
metadata_filer: {"company-data": {"conformed-name": "CARDINAL HEALTH INC", "cik": "0000721371", "assigned-sic": "5122", "irs-number": "310958666", "state-of-incorporation": "OH", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11373", "film-number": "22674360"}, "business-address": {"street1": "7000 CARDINAL PLACE", "city": "DUBLIN", "state": "OH", "zip": "43017", "phone": "6147573033"}, "mail-address": {"street1": "7000 CARDINAL PLACE", "city": "DUBLIN", "state": "OH", "zip": "43017"}, "former-company": {"former-conformed-name": "CARDINAL DISTRIBUTION INC", "date-changed": "19920703"}}
text: cah-20220225
  UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  WASHINGTON, DC 20549
  FORM
  8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d) of the
  Securities Exchange Act of 1934
  Date of Report (Date of earliest event reported):
  February 25, 2022
  Cardinal Health, Inc.
  (Exact Name of Registrant as Specified in Charter)
  Ohio
  1-11373
  31-0958666
  (State or Other Jurisdiction
  of Incorporation)
  (Commission
  File Number)
  (IRS Employer
  Identification No.)
  7000 Cardinal Place
  ,
  Dublin
  ,
  Ohio
  43017
  (Address of Principal Executive Offices) (Zip Code)
  (
  614
  )
  757-5000
  (Registrant's telephone number, including area code)
  Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
  see
  General Instruction A.2. below):
  ☐
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  ☐
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  ☐
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  ☐
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  Securities registered pursuant to Section 12(b) of the Act:
  Title of each class
  Trading Symbol(s)
  Name of each exchange on which registered
  Common shares (without par value)
  CAH
  New York Stock Exchange
  Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
  Emerging growth company
  ☐
  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
  ¨
  Item 1.01. Entry into a Material Definitive Agreement
  As of February 25, 2022, Cardinal Health, Inc. (the "Company") and two other national pharmaceutical distributors (collectively, the "Distributors") announced that each had independently determined that there is sufficient state and litigating subdivision participation to enter into the previously disclosed proposed settlement agreement (the "Settlement Agreement") to settle a substantial majority of opioid lawsuits filed by states and local governmental entities. The Settlement Agreement requires that participating states and territories, together with the Distributors, seek court-ordered consent judgments embodying the terms of the Settlement Agreement, which is anticipated to become effective on April 2, 2022.
  Under the terms of the Settlement Agreement, the Company would pay the participating states, territories and local governmental entities (the "Settling Governmental Entities") up to $6.0 billion over 18 years. A minimum of 85% of settlement payments must be used by the Settling Governmental Entities to remediate the opioid epidemic. The majority of the remaining payment amounts will be applied towards plaintiffs' attorneys' fees and costs. The Settlement Agreement also includes injunctive relief terms related to the Distributors' controlled substance anti-diversion programs. A monitor will be selected to oversee compliance with these provisions for a period of five years. The Distributors will also engage a third-party vendor to act as a clearinghouse for data aggregation and reporting, which the Distributors will fund for ten years and which will be available to the participating states to use in their anti-diversion efforts.
  The states of Florida, New York, Ohio, Rhode Island and Texas and their participating subdivisions, which have separate agreements with the Distributors, will participate in the Settlement Agreement pursuant to the terms of their separate agreements. As of the date of this Form 8-K, 46 of 49 eligible states, as well as the District of Columbia and all eligible U.S. territories, have agreed to join the Settlement Agreement. West Virginia subdivisions and Native American Tribes are not a part of the Settlement Agreement. A list of the states and territories that have agreed to the Settlement Agreement is attached hereto as Exhibit 99.1.
  Item 7.01. Regulation FD Disclosure
  The Distributors issued a joint news release on February 25, 2022 to announce the Settlement. A copy of this news release is attached to this Form 8-K as Exhibit 99.2.
  Item 9.01 Financial Statements and Exhibits
  (d) Exhibits
  Exhibit
  99.1
  List of participating states and territories
  99.2
  Joint news release issued by the Distributors on February 25, 2022
  2
  Signatures
  Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  Cardinal Health, Inc.
  (Registrant)
  Date:
  February 25, 2022
  By:
  /s/  JESSICA L. MAYER
  Jessica L. Mayer
  Chief Legal and Compliance Officer
  3